Issue brief: The status of drug-resistant malaria along the Thailand-Myanmar border
Emerging Plasmodium falciparum resistance to artemisinin derivatives continues to be major a global public health concern. There is a limited window of opportunity to contain resistant parasites before they spread around the world. Artemisinin-based combination therapies (ACTs) are recommended by WHO as the first-line treatment for uncomplicated malaria, and the scale-up of these highly effective medicine combinations has been integral to the remarkable recent successes in the fight against malaria. No other antimalarial medicines are available at present with the same level of efficacy and tolerability as ACTs.